Bipartisan Bills To Promote Drug Competition A Step Closer To Completion
The Two Bills Have Passed The Senate Judiciary Committee By Voice Vote
The Preserving Access to Affordable Generics and Biosimilars Act and the Stop STALLING Act are both a step closer to becoming law after passing voice votes in the Senate Judiciary Committee.
You may also be interested in...
Biosimilar insulin producers are facing calls to improve patient affordability after Eli Lilly implemented a $35 price cap on copays for its insulins in the private market and for the uninsured.
Ypsomed AG will manufacture insulin dosing injector pens for non-profit Civica. Civica has also paired up with AmerisourceBergen for generics supply chain support across the US.
With enactment of the drug pricing reform provisions in the Inflation Reduction Act, stakeholders now turn their attention to the implementing regulations that will be developed by the Centers for Medicare and Medicaid Services.